0 Axial Therapeutics to Present at the Inaugural Virtual H.C. Wainwright BioConnect ConferenceJanuary 6, 2021 READ MORE
0 Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company ConferenceDec. 8, 2020 READ MORE
2 Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other SymptomsResults to be Presented at The BRAIN Foundation Synchrony 2020 Conference Axial R&D Leader to Chair Day-long Session on Clinical Trials for ASD and New Therapeutics WALTHAM, Mass., Dec. 3, [...] READ MORE
0 Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNovember 25, 2020 READ MORE
0 Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci CapitalNovember 16, 2020 READ MORE
0 Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
1 Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease TherapeuticsJuly 28, 2020 READ MORE
